Modified serotype 28 adenoviral vectors
US9790519B2 · kind B2 · utility
6Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2013 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | May 28, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2810/6018
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a replication-deficient serotype 28 adenoviral vector characterized by comprising a portion of a serotype 45 adenoviral hexon protein and/or a portion of a serotype 45 fiber protein in place of the endogenous serotype 28 hexon and/or fiber protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.